login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
| Disease Info Index | ||||||||||||||||||||||||||
|
|
Von Recklinghausen's Disease
Drugs For Von Recklinghausen's Disease
Page Options
Von Recklinghausen's Disease | |
About |
|
Text 
|
Von Recklinghausen's disease is an inherited condition caused by genetic mutation. It is more commonly known as Neurofibromatosis (NF) Type 1. The disease derives its name from the German pathologist Friedrich Daniel von Recklinghausen who described it in 1882. NF is autosomal dominant, i.e. you only need to get the abnormal gene from one parent in order for you to inherit the disease.NF is perhaps the most common neurological disorder caused by a single gene. An abnormality in human chromosome 17 leads to the development of Von Recklinghausen''s disease.  Patients develop multiple soft tumours (neurofibromas) and very often skin spots (café au lait spots). NF has a prevalence of 1 in 3000 births.
|
Latest Publication and Research on Von Recklinghausen's Disease - Updated on 12/01/2011
Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia. - Published by PubMed
Hyaluronan in intra-operative edema of NF1-associated neurofibromas. - Published by PubMed
Neurofibromatosis 1 with pheochromocytoma. - Published by PubMed
Role of cortical sparing adrenalectomy and novel variant of mutation in patient with von Hippel-Lindau disease. - Published by PubMed
Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia. - Published by PubMed
Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia. - Published by PubMed
Hyaluronan in intra-operative edema of NF1-associated neurofibromas. - Published by PubMed
Neurofibromatosis 1 with pheochromocytoma. - Published by PubMed
Role of cortical sparing adrenalectomy and novel variant of mutation in patient with von Hippel-Lindau disease. - Published by PubMed
Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia. - Published by PubMed
| Share it! |  |
 |
 |
 |
 |
 |
 |
|
|
Comment & Contribute
| Citing this Health Article | ||||||
|
||||||
| News on Von Recklinghausen's Disease |
| * Nutritional Treatments as Good Targets of Gut-Central Nervous System Axis |
| * Skin-Tight Jeans Linked to Nerve Damage |
| * Scientists Identify Mutation Behind Rare Genetic Disorder |
| * Genetic Mutation Causing Rare Form of Signal Muscular Atrophy Identified |
| * Blocking Protein That Causes Nerve Damage Could Prevent MS |
| Total News Item 449 |
Are you a member of Facebook? Become a fan of Medindia and get breaking news delivered to your Facebook page.
